Clinical and dermoscopic features of atypical Spitz tumors: A multicenter, retrospective, case-control study - 15/10/15
Abstract |
Background |
Few studies have described the clinical and dermoscopic features of atypical Spitz tumors.
Objective |
We sought to describe the clinical and dermoscopic features of a series of atypical Spitz tumors as compared with those of conventional Spitz nevi.
Methods |
This was a multicenter, retrospective, case-control study, analyzing the clinical and dermoscopic characteristics of 55 atypical Spitz tumors and 110 Spitz nevi that were excised and diagnosed histopathologically.
Results |
The majority of atypical Spitz tumors presented clinically as a plaque or nodule, dermoscopically typified by a multicomponent or nonspecific pattern. A proportion of lesions (16.4%) exhibited the typical nonpigmented Spitzoid pattern of dotted vessels and white lines under dermoscopy. Nodularity, ulceration, linear vessels, polymorphic vessels, white lines, and blue-white veil were associated with atypical Spitz tumors by univariate analysis, but only nodularity and white lines remained significant after multivariate analysis. In contrast, a pigmented typical Spitzoid pattern was a potent predictor of Spitz nevi, associated with 6.5-fold increased probability.
Limitations |
Differentiation from Spitzoid melanoma and other nonmelanocytic lesions was not investigated.
Conclusion |
Atypical Spitz tumors are polymorphic melanocytic proliferations with a nodular clinical appearance. Dermoscopically they demonstrate a multicomponent and nonspecific pattern. A typical nonpigmented Spitzoid pattern on dermoscopy (with dotted vessels and white lines) does not exclude atypical Spitz tumors.
Le texte complet de cet article est disponible en PDF.Key words : atypical Spitz tumor, dermoscopy, histopathology, melanoma, skin cancer, Spitz nevus
Plan
Supported in part by the Italian Ministry of Health (RF-2010-2316524). Research at the Melanoma Unit in Hospital Clinic Barcelona is partially funded by grants 03/0019, 05/0302, 06/0265, 09/1393, and 12/00840 from Fondo de Investigaciones Sanitarias, Spain; by the CIBER de Enfermedades Raras of the Instituto de Salud Carlos III (Fondo Investigaciones Sanitarias FIS numbers 09/01393 and 12/00840), Spain; by the Agencia de Gestio d'Ajuts Universitaris i Recerca numbers AGAUR 2009 SGR 1337 and AGAUR 2014_SGR_603 of the Catalan Government, Spain; by the European Commission under the 6th Framework Programme, Contract No: LSHC-CT-2006-018702 (through GenoMEL); and by the National Cancer Institute of the US National Institutes of Health (CA83115). The sponsors had no role in the design and conduct of the study; in the collection, analysis and interpretation of data; or in the preparation, review, or approval of the manuscript. |
|
Conflicts of interest: None declared. |
Vol 73 - N° 5
P. 777-784 - novembre 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?